Yuchun Lee Vertex Pharmaceuticals Inc (VRTX) insider trading activity

Yuchun Lee is Director of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 1,875 shares of VRTX, which is worth approximately $968,887. The most recent transaction as insider was on Jan 27, 2023, when has been sold 1,429 shares (Common Stock) at a price of $322.28 per share, resulting in proceeds of $460,538. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.88K

0% 3M change

0% 12M change

Total Value Held $968,887

Yuchun Lee Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 27 2023	SELL Open market or private sale	$460,538 $322.28 p/Share	1,429 Reduced 43.25%	1,875 Common Stock
Jan 27 2023	BUY Exercise of conversion of derivative security	$103,088 $72.14 p/Share	1,429 Added 30.19%	3,304 Common Stock
Jan 26 2023	SELL Open market or private sale	$1,273,760 $318.44 p/Share	4,000 Reduced 68.09%	1,875 Common Stock
Jan 26 2023	BUY Exercise of conversion of derivative security	$288,560 $72.14 p/Share	4,000 Added 40.51%	5,875 Common Stock
Jan 25 2023	SELL Open market or private sale	$1,255,800 $313.95 p/Share	4,000 Reduced 68.09%	1,875 Common Stock
Jan 25 2023	BUY Exercise of conversion of derivative security	$288,560 $72.14 p/Share	4,000 Added 40.51%	5,875 Common Stock
Jan 24 2023	SELL Open market or private sale	$1,251,280 $312.82 p/Share	4,000 Reduced 68.09%	1,875 Common Stock
Jan 24 2023	BUY Exercise of conversion of derivative security	$288,560 $72.14 p/Share	4,000 Added 40.51%	5,875 Common Stock
Jan 23 2023	SELL Open market or private sale	$664,290 $312.02 p/Share	2,129 Reduced 53.17%	1,875 Common Stock
Jan 23 2023	BUY Exercise of conversion of derivative security	$153,586 $72.14 p/Share	2,129 Added 34.71%	4,004 Common Stock
Jan 18 2023	SELL Open market or private sale	$137,979 $312.17 p/Share	442 Reduced 19.08%	1,875 Common Stock
Jan 18 2023	BUY Exercise of conversion of derivative security	$31,885 $72.14 p/Share	442 Added 16.02%	2,317 Common Stock
Jan 17 2023	SELL Open market or private sale	$1,248,120 $312.03 p/Share	4,000 Reduced 68.09%	1,875 Common Stock
Jan 17 2023	BUY Exercise of conversion of derivative security	$288,560 $72.14 p/Share	4,000 Added 40.51%	5,875 Common Stock
Apr 18 2022	SELL Open market or private sale	$569,360 $284.68 p/Share	2,000 Reduced 51.61%	1,875 Common Stock
Apr 18 2022	BUY Exercise of conversion of derivative security	$163,080 $81.54 p/Share	2,000 Added 34.04%	3,875 Common Stock
Apr 14 2022	SELL Open market or private sale	$578,900 $289.45 p/Share	2,000 Reduced 51.61%	1,875 Common Stock
Apr 14 2022	BUY Exercise of conversion of derivative security	$163,080 $81.54 p/Share	2,000 Added 34.04%	3,875 Common Stock
Apr 13 2022	SELL Open market or private sale	$573,400 $286.7 p/Share	2,000 Reduced 51.61%	1,875 Common Stock
Apr 13 2022	BUY Exercise of conversion of derivative security	$163,080 $81.54 p/Share	2,000 Added 34.04%	3,875 Common Stock
Apr 12 2022	SELL Open market or private sale	$562,340 $281.17 p/Share	2,000 Reduced 51.61%	1,875 Common Stock
Apr 12 2022	BUY Exercise of conversion of derivative security	$163,080 $81.54 p/Share	2,000 Added 34.04%	3,875 Common Stock
Apr 11 2022	SELL Open market or private sale	$561,340 $280.67 p/Share	2,000 Reduced 51.61%	1,875 Common Stock
Apr 11 2022	BUY Exercise of conversion of derivative security	$163,080 $81.54 p/Share	2,000 Added 34.04%	3,875 Common Stock
Apr 08 2022	SELL Open market or private sale	$556,820 $278.41 p/Share	2,000 Reduced 51.61%	1,875 Common Stock

Yuchun Lee

Director

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX

Account